FDA
approval
· 2017-08-14
FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Original Application (Ascend Laboratories, LLC)
Summary
The FDA approved Ascend Laboratories' original application for a fixed-dose combination of amlodipine and olmesartan medoxomil for treating hypertension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for AMLODIPINE AND OLMESARTAN MEDOXOMIL (AMLODIPINE AND OLMESARTAN MEDOXOMIL)